Source- This post is based on the article “A case of JN.1, a subvariant of COVID19, found in Kerala as part of the ongoing routine surveillance by INSACOG” published in “PIB” on 16th December 2023. Why in the News? Recently a case of the JN.1 subvariant of COVID-19 has been identified in Kerala during the… Continue reading Emerging Threat: JN.1 Subvariant of COVID-19 Discovered in Kerala
Category: Factly: Science and Technology
This category contains all Current Affairs Factly Articles for Prelims, related to Science and Technology. You can find all relevant Science and Technology related updates on this page. This page is specifically useful for UPSC Prelims exam.
Kakrapar-4 nuclear reactor attains criticality
Source: The post is based on the article “Kakrapar-4 nuclear reactor attains criticality” published in “The Hindu” on 18th December 2023 Why in the News? The Fourth unit of the Kakrapar Atomic Power Project (KAPP-4) in Gujarat has achieved criticality. What is Criticality? Criticality refers to the state where the chain reaction of nuclear fission… Continue reading Kakrapar-4 nuclear reactor attains criticality
Cyberthreats: Centre sets up secure e-mail network for staff of critical departments
Source- This post is based on the article “Centre sets up secure e-mail for 10,000 users in critical ministries” published in “The Hindu” on 17th December 2023. Why in the News? In response to cyber attacks, the Centre has implemented a secure email system for 10,000 users across critical ministries and departments. How will it… Continue reading Cyberthreats: Centre sets up secure e-mail network for staff of critical departments
Dare To Dream (D2D) Scheme + Infographic
Source- This post is based on the article “DARE TO DREAM SCHEME” published in “PIB” on 15th December 2023. Why in the News? Recently Minister of State for Defence has filed a reply in Parliament regarding the successful implementation of the Dare to Dream (D2D) scheme. What is Dare to Dream (D2D) Scheme? Aspect Details… Continue reading Dare To Dream (D2D) Scheme + Infographic
Web browsers working
Source- This post is based on the article “How do web browsers work? | Explained” published in “The Hindu” on 11th December 2023. Why in the News? Web browsers serve as our digital gateways to the expansive realm of the internet. In this article we delve into the complexity of web browsers, unveiling their working… Continue reading Web browsers working
New Delhi Declaration on Artificial Intelligence Adopted
Source: The post is based on the article “New Delhi Declaration on Artificial Intelligence adopted” published in “The Hindu” on 14th December 2023 Why in the News? The New Delhi Declaration has been adopted at the Global Partnership on Artificial Intelligence (GPAI) Summit. It is being hosted by India at the Bharat Mandapam, New Delhi.… Continue reading New Delhi Declaration on Artificial Intelligence Adopted
AKTOCYTE tablets – Revolutionizing Cancer Care + Infographic
Source– This post is based on the article “Breakthrough Nutraceutical ‘AKTOCYTE’ by the Department of Atomic Energy Set to Transform Cancer Care” published in “PIB” on 13th December 2023. Why in the News? AKTOCYTE tablets have been granted approval by the Food Safety and Standards Authority of India (FSSAI). What are AKTOCYTE tablets? Specifications Details… Continue reading AKTOCYTE tablets – Revolutionizing Cancer Care + Infographic
EU Artificial Intelligence Act: What does the world’s first law on regulating AI propose?
Source: The post is based on the article “EU ‘historic’ deal: What does the world’s first law on regulating AI propose?” published in “Indian Express” on 11th December 2023 Why in the News? European Union (EU) lawmakers have reached a provisional deal on a comprehensive set of rules regulating the use of artificial intelligence (AI).… Continue reading EU Artificial Intelligence Act: What does the world’s first law on regulating AI propose?
DRESS Syndrome: Painkiller Meftal can have adverse reactions; govt issues drug safety alert
Source: The post is based on the article “DRESS Syndrome: Painkiller Meftal can have adverse reactions; govt issues drug safety alert” published in “Business Standard” on 8th December 2023 Why in the News? The Indian Pharmacopoeia Commission (IPC) has warned about risks linked to the painkiller Meftal. They have cautioned about possible harmful reactions with… Continue reading DRESS Syndrome: Painkiller Meftal can have adverse reactions; govt issues drug safety alert
Lyfgenia and Casgevy: U.S FDA approves gene therapies for sickle cell disease
Source: The post is based on the article “Lyfgenia and Casgevy: U.S FDA approves gene therapies for sickle cell disease” published in “The Hindu” on 9th December 2023 Why in the News? The U.S Food and Drug Administration (FDA) has approved a pair of gene therapies named Lyfgenia and Casgevy for the treatment of sickle… Continue reading Lyfgenia and Casgevy: U.S FDA approves gene therapies for sickle cell disease

